Novan
BiotechUSAClosed 2023
Total Raised
Undisclosed
Peak Valuation
Undisclosed
Employees
—
Year Collapsed
2023
Business model
Medical dermatology products based on nitric oxide-releasing technology.
In brief
Developed a dermatology drug platform based on nitric oxide-releasing technology, targeting conditions like molluscum contagiosum, but struggled to translate FDA approval into profitable commercial sales. Unable to continue funding operations independently, it filed for Chapter 1…
See the What Happened tab for the full account.
Key facts
- Founded
- 2006
- Closed
- 2023
- Headquarters
- Durham, USA
- Industry
- Biotech
- Employees
- —
- Revenue
- Undisclosed
- Founders
- Nathan Stasko
Related failures
Vedere Bio
2019–2023Biotech · USA
Ran out of funding$77M9 Meters Biopharma
2016–2023Biotech · USA
Ran out of fundingUndisclosedAcorda Therapeutics
1995–2024Biotech · USA
Ran out of fundingUndisclosedAthersys
1995–2024Biotech · USA
Ran out of fundingUndisclosedEiger BioPharmaceuticals
2008–2024Biotech · USA
Ran out of fundingUndisclosedHumanigen
1999–2024Biotech · USA
Ran out of fundingUndisclosed
Often compared with: Galderma, Ortho Dermatologics.